BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7741720)

  • 1. c-fos and bone loss: a proto-oncogene regulates osteoclast lineage determination.
    Jacenko O
    Bioessays; 1995 Apr; 17(4):277-81. PubMed ID: 7741720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation.
    Matsuo K; Owens JM; Tonko M; Elliott C; Chambers TJ; Wagner EF
    Nat Genet; 2000 Feb; 24(2):184-7. PubMed ID: 10655067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.
    Lee MS; Kim HS; Yeon JT; Choi SW; Chun CH; Kwak HB; Oh J
    J Immunol; 2009 Sep; 183(5):3390-9. PubMed ID: 19641137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1.
    Tondravi MM; McKercher SR; Anderson K; Erdmann JM; Quiroz M; Maki R; Teitelbaum SL
    Nature; 1997 Mar; 386(6620):81-4. PubMed ID: 9052784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commitment and differentiation of stem cells to the osteoclast lineage.
    Hayashi S; Yamane T; Miyamoto A; Hemmi H; Tagaya H; Tanio Y; Kanda H; Yamazaki H; Kunisada T
    Biochem Cell Biol; 1998; 76(6):911-22. PubMed ID: 10392705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling.
    Grigoriadis AE; Wang ZQ; Cecchini MG; Hofstetter W; Felix R; Fleisch HA; Wagner EF
    Science; 1994 Oct; 266(5184):443-8. PubMed ID: 7939685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CSF-1 in bone and bone marrow development.
    Cecchini MG; Hofstetter W; Halasy J; Wetterwald A; Felix R
    Mol Reprod Dev; 1997 Jan; 46(1):75-83; discussion 83-4. PubMed ID: 8981367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.
    Park CK; Kim HJ; Kwak HB; Lee TH; Bang MH; Kim CM; Lee Y; Chung DK; Baek NI; Kim J; Lee ZH; Kim HH
    Int Immunopharmacol; 2007 Dec; 7(12):1507-16. PubMed ID: 17920527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation.
    Bakiri L; Takada Y; Radolf M; Eferl R; Yaniv M; Wagner EF; Matsuo K
    Bone; 2007 Apr; 40(4):867-75. PubMed ID: 17189721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bavachalcone inhibits osteoclast differentiation through suppression of NFATc1 induction by RANKL.
    Park CK; Lee Y; Chang EJ; Lee MH; Yoon JH; Ryu JH; Kim HH
    Biochem Pharmacol; 2008 Jun; 75(11):2175-82. PubMed ID: 18433733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent expression of proto-oncogene c-fos stimulates osteoclast differentiation.
    Miyauchi A; Kuroki Y; Fukase M; Fujita T; Chihara K; Shiozawa S
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1547-55. PubMed ID: 7811235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge.
    Kim HH; Kim JH; Kwak HB; Huang H; Han SH; Ha H; Lee SW; Woo ER; Lee ZH
    Biochem Pharmacol; 2004 May; 67(9):1647-56. PubMed ID: 15081864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone remodeling and macrophage differentiation in osteopetrosis (op) mutant mice defective in the production of macrophage colony-stimulating factor.
    Takatsuka H; Umezu H; Hasegawa G; Usuda H; Ebe Y; Naito M; Shultz LD
    J Submicrosc Cytol Pathol; 1998 Apr; 30(2):239-47. PubMed ID: 9648288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopetroses and immunodeficiencies in humans.
    Villa A; Vezzoni P; Frattini A
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):421-7. PubMed ID: 17088646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of osteoclast differentiation induced by IL-1.
    Kim JH; Jin HM; Kim K; Song I; Youn BU; Matsuo K; Kim N
    J Immunol; 2009 Aug; 183(3):1862-70. PubMed ID: 19587010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
    Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K
    J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fra-1 potentiates osteoclastic differentiation in osteoclast-macrophage precursor cell lines.
    Owens JM; Matsuo K; Nicholson GC; Wagner EF; Chambers TJ
    J Cell Physiol; 1999 May; 179(2):170-8. PubMed ID: 10199556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
    Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
    Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation.
    Glass DA; Karsenty G
    Ann N Y Acad Sci; 2006 Apr; 1068():117-30. PubMed ID: 16831912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.